Jun 22, 2022 ProMIS Neurosciences Announces Filing of Form 10 Registration Statement and Nasdaq Listing Application
May 3, 2022 Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend ProMIS Shareholders Vote FOR All Proposed Items at the Upcoming Annual and Special Meeting of Shareholders
Apr 28, 2022 ProMIS Neurosciences Reports New Milestones in Potential Therapeutic Approaches for Amyotrophic Lateral Sclerosis (ALS)